miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. Prognosis is poor, and therapeutic options are limited. MicroRNAs (miRNAs) have emerged as potential therapeutic molecules against cancer. Here, we investigated the therapeutic efficacy of miR-199a-3p, an m...
Saved in:
Main Authors: | Elisa Callegari (Author), Lucilla D'Abundo (Author), Paola Guerriero (Author), Carolina Simioni (Author), Bahaeldin K. Elamin (Author), Marta Russo (Author), Alice Cani (Author), Cristian Bassi (Author), Barbara Zagatti (Author), Luciano Giacomelli (Author), Stella Blandamura (Author), Farzaneh Moshiri (Author), Simona Ultimo (Author), Antonio Frassoldati (Author), Giuseppe Altavilla (Author), Laura Gramantieri (Author), Luca Maria Neri (Author), Silvia Sabbioni (Author), Massimo Negrini (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
by: Elisa Callegari, et al.
Published: (2022) -
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
by: Elisa Callegari, et al.
Published: (2022) -
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer
by: Elisa Callegari, et al.
Published: (2019) -
Authors' response to 2017-199 LtoEd
by: Geza Benke, et al.
Published: (2018) -
Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis
by: Ni Zeng, et al.
Published: (2021)